Skip to main content
Clinical Trials/EUCTR2013-003234-32-DE
EUCTR2013-003234-32-DE
Active, not recruiting
Phase 1

Pathological changes in the myocardial microvasculature - a MR-based quantification - Myo-Mikro-Quant

niversitätsklinikum Münster0 sites125 target enrollmentMarch 24, 2014

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
niversitätsklinikum Münster
Enrollment
125
Status
Active, not recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 24, 2014
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional clinical trial of medicinal product

Investigators

Sponsor
niversitätsklinikum Münster

Eligibility Criteria

Inclusion Criteria

  • \- cardiac disease with suspected microvasculopathy (hypertension, chronic myocardial infarction, hypertrophic cardiomyopathy, post\-heart transplantation, cardiac dystrophinopathy)
  • \- age \>18 years
  • \- ability to give written informed consent
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years) yes
  • F.1\.2\.1 Number of subjects for this age range 125
  • F.1\.3 Elderly (\>\=65 years) no
  • F.1\.3\.1 Number of subjects for this age range 0

Exclusion Criteria

  • \- contraindications to magnetic resonance imaging
  • \- contraindications to Feraheme or Magnevist
  • \- asthma / allergic predisposition
  • \- pregnancy

Outcomes

Primary Outcomes

Not specified

Similar Trials